Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring differences in protein cargo of extracellular vesicles from ME/CFS patient plasma compared to healthy controls.

Biochemistry and biophysics reports·2026
Same author

Menopause and ageing in women with multiple sclerosis.

Frontiers in neurology·2026
Same author

A Unique Intraexonic Splicing Mechanism in the Immunoglobulin Domain of NKp30 Produces a Surface-Expressed Receptor With Altered Ligand Specificity.

European journal of immunology·2026
Same author

Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort.

Frontiers in immunology·2026
Same author

Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study.

European journal of neurology·2026
Same author

Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab.

BMJ neurology open·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Related Experiment Video

Updated: May 27, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

[New gene map for multiple sclerosis].

Hanne F Harbo1, Aslaug R Lorentzen, Benedicte A Lie

  • 1Nevrologisk avdeling, Oslo universitetssykehus, Ullevål, Norway. h.f.harbo@medisin.uio.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|November 4, 2011
PubMed
Summary
This summary is machine-generated.

Genetic studies reveal over 50 risk-gene regions for multiple sclerosis (MS), highlighting immune pathways. These findings advance understanding of MS etiology and potential therapeutic targets.

Related Experiment Videos

Last Updated: May 27, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Area of Science:

  • Neuroimmunology
  • Genetics
  • Epidemiology

Context:

  • Multiple sclerosis (MS) is a chronic, inflammatory central nervous system disease affecting young adults.
  • The exact causes of MS remain unknown, though genetic and environmental factors are implicated.
  • Understanding genetic risk factors is crucial for elucidating MS pathogenesis.

Purpose:

  • To provide an overview of current knowledge regarding genetic risk factors for MS.
  • To synthesize findings from recent genome-wide association studies (GWAS) and replication studies.
  • To highlight the role of immune-related genes in MS etiology.

Summary:

  • Large-scale international collaborations have identified over 50 MS risk-gene regions beyond the HLA loci.
  • Genome-wide association studies involving thousands of patients and controls revealed numerous novel MS-associated gene regions.
  • The majority of identified MS risk loci are associated with immune system molecules, underscoring the role of immune pathways.

Impact:

  • These discoveries significantly expand the understanding of the genetic architecture of MS.
  • The identified genetic factors collectively emphasize the importance of immune-related pathways in MS development.
  • This knowledge may pave the way for novel diagnostic and therapeutic strategies for multiple sclerosis.